{"entity":{"type":"insider","cik":"0001676880","url":"/insider/0001676880","json_url":"/insider/0001676880.json","name":"Cooper Ronald Harold Wilfred","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2018-08-16","last":"2024-10-01","span_basis":"filed_date"},"name_variants":[{"name":"Cooper Ronald Harold Wilfred","source":"filing","n_filings":9,"first_seen":"2018-08-16","last_seen":"2024-10-01"}],"transactions":[{"id":3067331,"accession":"0000929638-24-003358","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-24-003358","line_url":"/filing/0000929638-24-003358#line-1","is_derivative":false,"issuer_cik":"0001676880","issuer_name":"enGene Holdings Inc.","issuer_ticker":"ENGN","issuer_name_source":null,"issuer_url":"/issuer/0001676880","owner_cik":"0001676880","owner_name":"Cooper Ronald Harold Wilfred","owner_display_name":"Cooper Ronald Harold Wilfred","owner_url":"/insider/0001676880","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.7,"price_display":"5.70","price_state":"stated","total_value":57000.0,"total_display":"57,000.00","total_whole":"57,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-10-01","scope":"insider"},{"id":8104515,"accession":"0001209191-23-004448","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004448","line_url":"/filing/0001209191-23-004448#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001676880","owner_name":"Cooper Ronald Harold Wilfred","owner_display_name":"Cooper Ronald Harold Wilfred","owner_url":"/insider/0001676880","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1057.0,"shares_display":"1,057","price_per_share":43.8,"price_display":"43.80","price_state":"stated","total_value":46296.6,"total_display":"46,296.60","total_whole":"46,297","shares_owned_after":57444.0,"shares_owned_after_display":"57,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-23","scope":"insider"},{"id":9271879,"accession":"0001209191-23-002632","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002632","line_url":"/filing/0001209191-23-002632#line-1","is_derivative":false,"issuer_cik":"0001676880","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001676880","owner_cik":"0001676880","owner_name":"Cooper Ronald Harold Wilfred","owner_display_name":"Cooper Ronald Harold Wilfred","owner_url":"/insider/0001676880","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":919.0,"shares_display":"919","price_per_share":19.5764,"price_display":"19.58","price_state":"stated","total_value":17990.7116,"total_display":"17,990.71","total_whole":"17,991","shares_owned_after":58501.0,"shares_owned_after_display":"58,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2023-01-09","scope":"insider"},{"id":6957323,"accession":"0001209191-22-054485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054485","line_url":"/filing/0001209191-22-054485#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001676880","owner_name":"Cooper Ronald Harold Wilfred","owner_display_name":"Cooper Ronald Harold Wilfred","owner_url":"/insider/0001676880","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":919.0,"shares_display":"919","price_per_share":19.5764,"price_display":"19.58","price_state":"stated","total_value":17990.7116,"total_display":"17,990.71","total_whole":"17,991","shares_owned_after":55461.0,"shares_owned_after_display":"55,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-25","scope":"insider"},{"id":6631183,"accession":"0001209191-22-043097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043097","line_url":"/filing/0001209191-22-043097#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001676880","owner_name":"Cooper Ronald Harold Wilfred","owner_display_name":"Cooper Ronald Harold Wilfred","owner_url":"/insider/0001676880","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":929.0,"shares_display":"929","price_per_share":24.6745,"price_display":"24.67","price_state":"stated","total_value":22922.6105,"total_display":"22,922.61","total_whole":"22,923","shares_owned_after":56380.0,"shares_owned_after_display":"56,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-25","scope":"insider"},{"id":6250958,"accession":"0001209191-22-025523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025523","line_url":"/filing/0001209191-22-025523#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001676880","owner_name":"Cooper Ronald Harold Wilfred","owner_display_name":"Cooper Ronald Harold Wilfred","owner_url":"/insider/0001676880","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":907.0,"shares_display":"907","price_per_share":33.11,"price_display":"33.11","price_state":"stated","total_value":30030.77,"total_display":"30,030.77","total_whole":"30,031","shares_owned_after":56082.0,"shares_owned_after_display":"56,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-22","filed_date":"2022-04-25","scope":"insider"},{"id":6541478,"accession":"0001209191-22-004801","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-004801","line_url":"/filing/0001209191-22-004801#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001676880","owner_name":"Cooper Ronald Harold Wilfred","owner_display_name":"Cooper Ronald Harold Wilfred","owner_url":"/insider/0001676880","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3684.0,"shares_display":"3,684","price_per_share":24.8822,"price_display":"24.88","price_state":"stated","total_value":91666.0248,"total_display":"91,666.02","total_whole":"91,666","shares_owned_after":56989.0,"shares_owned_after_display":"56,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-25","scope":"insider"},{"id":6338104,"accession":"0001209191-18-058716","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-058716","line_url":"/filing/0001209191-18-058716#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001676880","owner_name":"Cooper Ronald Harold Wilfred","owner_display_name":"Cooper Ronald Harold Wilfred","owner_url":"/insider/0001676880","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1026.0,"shares_display":"1,026","price_per_share":25.0177,"price_display":"25.02","price_state":"stated","total_value":25668.1602,"total_display":"25,668.16","total_whole":"25,668","shares_owned_after":7760.0,"shares_owned_after_display":"7,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-13","filed_date":"2018-11-15","scope":"insider"},{"id":6765080,"accession":"0001209191-18-047055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-047055","line_url":"/filing/0001209191-18-047055","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001676880","owner_name":"Cooper Ronald Harold Wilfred","owner_display_name":"Cooper Ronald Harold Wilfred","owner_url":"/insider/0001676880","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":788.0,"shares_display":"788","price_per_share":31.850812182741116,"price_display":"31.85","price_state":"stated","total_value":25098.44,"total_display":"25,098.44","total_whole":"25,098","shares_owned_after":6534.0,"shares_owned_after_display":"6,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001980845","name":"enGene Holdings Inc.","url":"/issuer/0001980845","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2024-10-01","last_seen":"2024-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001322505","name":"ALBIREO PHARMA, INC.","url":"/issuer/0001322505","role":"Director, Officer (President and CEO)","n_filings":8,"first_seen":"2018-08-16","last_seen":"2023-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001676880","retrieved_at":"2026-08-24T23:15:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}